Clinical Research Directory
Browse clinical research sites, groups, and studies.
6 clinical studies listed.
Filters:
Tundra lists 6 Paraplegia and Tetraplegia clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.
This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.
NCT06814015
Self-balancing Personal Exoskeleton for SCI (Site 2)
This study aims to demonstrate the safety and effectiveness of the personal exoskeleton in individuals with spinal cord injury (SCI).
Gender: All
Ages: 18 Years - Any
Updated: 2026-10-29
2 states
NCT06777576
Self-balancing Personal Exoskeleton for SCI
This study aims to demonstrate the safety and effectiveness of the Eve personal exoskeleton in individuals with spinal cord injury (SCI).
Gender: All
Ages: 18 Years - Any
Updated: 2026-10-29
2 states
NCT07767955
Healthcare Professionals' Satisfaction With Various Exoskeleton Models
The recent increase in the use of exoskeletons in rehabilitation therapies is bringing important changes to the healthcare professional's work routine. However, despite the importance of user feedback on the development of these novelties, research on this topic remains scarce. The purpose of this study was to compare the satisfaction of healthcare professionals (physiotherapists and physical education instructors) with different exoskeletons. This exploratory case series evaluated healthcare professionals' perspectives and compared the usability of 3 different exoskeleton devices used for gait trainning. A group of 14 rehabilitation specialists with at least six months of experience in exoskeleton operation were interviewed to evaluate qualitative aspects and answered a System Usability Scale (SUS) questionnaire.
Gender: All
Updated: 2026-08-17
1 state
NCT07625332
Pilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI)
The purpose of this research study is to measure the tolerability and preliminary efficacy of a drug, galantamine, to treat metabolic syndrome (MetS) by reducing circulating inflammation in people with spinal cord injury (SCI). Galantamine is FDA-approved for the treatment of Alzheimer's disease. Here, the drug is considered experimental for the purposes of this study.
Gender: All
Ages: 21 Years - 75 Years
Updated: 2026-06-04
2 states
NCT07536386
Self-balancing Personal Exoskeleton for SCI (WIP)
This study aims to demonstrate the safety and effectiveness of the personal exoskeleton in individuals with spinal cord injury (SCI).
Gender: All
Ages: 18 Years - Any
Updated: 2026-04-17
NCT07222033
Self-balancing Personal Exoskeleton for SCI (WINY)
This study aims to demonstrate the safety and effectiveness of the personal exoskeleton in individuals with spinal cord injury (SCI).
Gender: All
Ages: 18 Years - Any
Updated: 2026-02-02
1 state